Posts

ulrich medical USA® Delivers Four Consecutive Years of Double-Digit Growth

ST. LOUIS, MO (March 2, 2015) – ulrich medical USA Inc., today announced a strong financial performance for the year ending December 31, 2014. The company recorded a 15 percent annual growth rate in 2014, which caps off four consecutive years of profitable, double-digit growth for the company.

Read more

ulrich medical USA® Reports Record Results for Third Consecutive Year

Expands Current Product Portfolio to Create New Hospital Devices Business Unit

ST. LOUIS, MO (February 26, 2014) – ulrich medical USA, Inc., today announced record revenue growth for the year ending December 31, 2013. The company recorded a 22 percent growth rate in 2013, in addition to its previously reported 13 percent revenue growth in 2012 and 20 percent growth in 2011.

Read more

ulrich medical USA® Honored with Best of Chesterfield Award

101-Year-Old Spinal Implant Company Recognized for Long-Term Value to Chesterfield, Missouri

ST. LOUIS, MO (December 16, 2013) – ulrich medical USA, Inc., has been selected for the 2013 Best of Chesterfield Award in the Medical Device Company category by the Chesterfield Award Program.

Read more

ulrich medical USA® Expands U.S. Corporate Headquarters

Spinal Implant Company Positions for Explosive Growth

ST. LOUIS, MO (September 25, 2013) – ulrich medical USA, Inc., today announced that it has moved its U.S. corporate headquarters to meet the demands of its rapid growth. The new facility at 18221 Edison Avenue, Chesterfield, Missouri 63005 is more than three times larger than its former location.

Read more

ulrich medical USA™ Reports Record Results for Two Consecutive Years

ST. LOUIS, MO (January 23, 2013) – ulrich medical USA, Inc., today announced record results for the year ending December 31, 2012. The company recorded a 13 percent compound annual growth rate for calendar year 2012 and a 34 percent growth rate for the combined periods of 2011 and 2012.

Read more

ulrich medical USA™ Announces 6,500 Implantation Milestone

Provides Objective Evidence of U.S. Spine Market Leadership in Expandable VBR® Titanium Cage Technologies for Trauma/Tumor

ST. LOUIS, MO (September 5, 2012) – ulrich medical USA, Inc. today announced the successful completion of 6,500 corpectomy surgeries performed in 48 states using the company’s expandable vertebral body replacement devices.

Read more

ulrich medical USA™ Releases New Expandable Spinal Implant for U.S. Market

Strengthens Flagship Market Position in Expandable VBR® Titanium Cage Technologies

ST. LOUIS, MO (April 23, 2012) – ulrich medical USA, Inc., today announced the release of the Omni VBR™ Implant System, a new titanium vertebral body replacement device that is intended for use in the thoracic and lumbar spine (T1-L5) to replace a collapsed, damaged or unstable vertebral body due to tumor or trauma.

Read more

ulrich medical USA™ Announces Two Product Line Enhancements

Bolsters Spine Market Leadership Position in Expandable VBR® Titanium Cage Technologies

ST. LOUIS, MO (April 2, 2012) – ulrich medical USA, Inc. today announced the release of two important product line enhancements to their growing spinal implant portfolio of expandable cage technologies.

Read more

ulrich medical USA™ Reports Record Results for 2011

ST. LOUIS, MO (March 8, 2012) – ulrich medical USA, Inc., today announced record results for the year ending December 31, 2011. The company recorded a compound annual growth rate of 20% for the year which is the best performance in the history of the company since its inception in 2006.

Read more